Galactosylceramide: a reliable serum index of demyelination in multiple sclerosis. 1989

C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
Laboratoire de neurobiologie cellulaire, moléculaire, et clinique, INSERM U-134, Hôpital de la Salpêtrière, Paris, France.

Eight patients with multiple sclerosis were followed for several months to determine if serum levels of galactosylceramide, a major lipid component of myelin, correlate with the clinical evolution of the disease. In the patients with the chronic progressive form of multiple sclerosis, galactosylceramide remained undetectable. In the patients with relapsing-remitting multiple sclerosis, there was a good correlation between the elevation of serum galactosylceramide levels and clinical relapses. This serum assay should prove of value in the follow-up of patients with multiple sclerosis.

UI MeSH Term Description Entries
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002554 Cerebrosides Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)
D005260 Female Females
D005699 Galactosylceramides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Galactocerebrosides,Galactosyl Ceramide,Galactosyl Ceramides,Galactosylceramide,Ceramide, Galactosyl,Ceramides, Galactosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
January 2014, Handbook of clinical neurology,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
October 1972, Fortschritte der Medizin,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
July 1980, Neurology,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
September 2023, Multiple sclerosis (Houndmills, Basingstoke, England),
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
October 1973, Journal of the neurological sciences,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
September 2007, Journal of neuropathology and experimental neurology,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
August 2008, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
January 2023, Current protein & peptide science,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
August 2017, Journal of mathematical biology,
C Lubetzki, and Y Thuillier, and A Galli, and O Lyon-Caen, and F Lhermitte, and B Zalc
January 2012, Nature reviews. Neurology,
Copied contents to your clipboard!